Temozolomide in Treating Patients With Recurrent Malignant Glioma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00004113
Recruitment Status : Completed
First Posted : May 21, 2004
Last Update Posted : June 19, 2013
National Cancer Institute (NCI)
Information provided by:
Memorial Sloan Kettering Cancer Center

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Primary Completion Date : October 2001
  Study Completion Date : October 2001